12006323 | Ethynyl derivatives | May 09, 21 | Jun 11, 24 | Hoffmann-La Roche, Inc. |
12006366 | Methods and compositions for preventing type 1 diabetes | Jun 11, 21 | Jun 11, 24 | Provention Bio, Inc.; Yale University; Benaroya Research Institure at Virginia Mason; |
11998542 | Compositions and methods for reducing major adverse cardiovascular events | Nov 16, 20 | Jun 04, 24 | Nalpropion Pharmaceuticals LLC |
11999677 | Benzylamino-oxoethyl benzamide analogs and methods of use | Feb 08, 22 | Jun 04, 24 | The Board of Regents of the University of Oklahoma |
11999722 | Disubstituted pyrazole compounds | Sep 17, 21 | Jun 04, 24 | Applied Molecular Evolution Inc. c/o Eli Lilly and Company Patent Division |
11999740 | Fused pyrazine derivatives as A2A / A2B inhibitors | Oct 13, 21 | Jun 04, 24 | Incyte Corporation |
11992477 | Pharmaceutical combination, composition, and combination preparation comprising glucokinase activator and SGLT-2 inhibitor and preparation methods and uses thereof | May 28, 19 | May 28, 24 | Hua Medicine (Shanghai) Ltd. |
11992487 | Quinolines that modulate SERCA and their use for treating disease | Aug 02, 23 | May 28, 24 | Neurodon Corporation |
11992506 | Stem cell derived pancreatic islet differentiation | Nov 01, 22 | May 28, 24 | Vertex Pharmaceuticals Incorporated |
11987619 | Single-chain chimeric polypeptides and uses thereof | Jul 21, 22 | May 21, 24 | HCW Biologics, Inc. |
11980614 | Methods of treating RBP4 related diseases with triazolopyridines | Apr 12, 21 | May 14, 24 | Belite Bio, Inc; The Trustees of Columbia University in the City of New York; |
11981928 | Methods for reducing elevated glucose levels | Sep 28, 18 | May 14, 24 | SDF BIOPHARMA INC. |
11974989 | Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs | Feb 18, 21 | May 07, 24 | vTv Therapeutics LLC |
11974990 | TXNIP-TRX complex inhibitors and methods of using the same | Apr 06, 22 | May 07, 24 | City of Hope |
11976083 | Inhibitors of peptidylarginine deiminases | Apr 28, 21 | May 07, 24 | Gilead Sciences, Inc. |
11976282 | GATA3 inhibitors for the promotion of subcutaneous fat deposition | Jun 23, 20 | May 07, 24 | QATAR UNIVERSITY |
11969435 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | Dec 07, 21 | Apr 30, 24 | Corcept Therapeutics, Inc. |
11970523 | Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof | May 06, 19 | Apr 30, 24 | China Pharmaceutical University |
11963947 | Pharmaceutical combination, composition and compound preparation comprising glucokinase activator and DPP-IV inhibitor, and preparation method and use thereof | May 28, 19 | Apr 23, 24 | Hua Medicine (Shanghai) Ltd. |
11963989 | Application of medical cell CMU-pb-7 in preparation of blood lipid-lowering drugs | Jun 17, 23 | Apr 23, 24 | GUANGDONG XINGHAI BIOTECHNOLOGY CO., LTD.; GUANGDONG XINGHAI INSTITUTE OF CELL; |